TermSheet
Series A round closed
Loyal Series A Round / 100% filled
Founder at Loyal

CELINE HALIOUA

Celine is the founder and CEO of Loyal, building medicines intended to extend dog healthspan and lifespan.

FounderSan Francisco, CA
Back to Series A RoundView Loyal
Mission

Why I'm building Loyal

Celine has worked across longevity science, animal health, and biotech company building.

Links

LoyalInvest
loyal.comloyal.comcelinehh.comlinkedin.com/in/celinehhhttps://loyal.comhttps://www.celinehh.comhttps://www.linkedin.com/in/celinehh

Companies

LoyalClinical-stage animal health company developing dog longevity drugs.Series A Closed

Experience

Longevity FundChief of Staff
Previous role
OxfordDPhil student
Previous role
Studied neuroscience and nanobiotechnologyExperience
Previous role
University of OxfordD.Phil. student
Previous role

Notes

Note 01Founder and CEO of Loyal
Note 02Previously Chief of Staff at Longevity Fund
Note 03Focused on FDA-regulated longevity medicine
Note 04Founded Loyal in 2019 to develop drugs intended to extend dog lifespan.
Note 05Leads Loyal as founder and CEO.
Note 06Previously served as Chief of Staff to Laura Deming at Longevity Fund.
Note 07Background spans gene therapy economics, neuroscience, and nanobiotechnology.